Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 27 | 2023 | 784 | 4.550 |
Why?
|
| Hernia, Inguinal | 15 | 2024 | 75 | 3.690 |
Why?
|
| Herniorrhaphy | 15 | 2024 | 91 | 3.250 |
Why?
|
| Peritoneal Dialysis | 4 | 2023 | 31 | 2.260 |
Why?
|
| Kidney Failure, Chronic | 5 | 2023 | 432 | 1.630 |
Why?
|
| Simulation Training | 7 | 2022 | 108 | 1.430 |
Why?
|
| Catheters, Indwelling | 4 | 2023 | 113 | 1.420 |
Why?
|
| Catheterization | 4 | 2023 | 237 | 1.180 |
Why?
|
| Quality of Life | 15 | 2024 | 1816 | 1.140 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 3 | 2015 | 9 | 1.140 |
Why?
|
| Recurrence | 6 | 2024 | 1211 | 1.040 |
Why?
|
| Hernia, Abdominal | 3 | 2021 | 14 | 0.980 |
Why?
|
| Obesity | 3 | 2024 | 1030 | 0.920 |
Why?
|
| Surgical Mesh | 8 | 2023 | 125 | 0.910 |
Why?
|
| Peritoneum | 3 | 2023 | 55 | 0.870 |
Why?
|
| Edema | 2 | 2015 | 73 | 0.850 |
Why?
|
| Curriculum | 8 | 2022 | 615 | 0.800 |
Why?
|
| Abdominal Wall | 2 | 2020 | 32 | 0.760 |
Why?
|
| Gastroesophageal Reflux | 5 | 2022 | 121 | 0.710 |
Why?
|
| Cholecystectomy, Laparoscopic | 4 | 2022 | 52 | 0.650 |
Why?
|
| Internship and Residency | 5 | 2022 | 1134 | 0.630 |
Why?
|
| Rectus Abdominis | 2 | 2017 | 41 | 0.620 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 367 | 0.590 |
Why?
|
| Obesity, Morbid | 7 | 2022 | 247 | 0.560 |
Why?
|
| Bariatric Surgery | 5 | 2022 | 207 | 0.530 |
Why?
|
| Treatment Outcome | 23 | 2023 | 9167 | 0.520 |
Why?
|
| Surgeons | 4 | 2022 | 298 | 0.520 |
Why?
|
| Retrospective Studies | 24 | 2024 | 10273 | 0.510 |
Why?
|
| Fundoplication | 7 | 2022 | 73 | 0.510 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 77 | 0.500 |
Why?
|
| Hernia, Hiatal | 3 | 2023 | 36 | 0.490 |
Why?
|
| Pyloromyotomy | 3 | 2021 | 13 | 0.490 |
Why?
|
| Omentum | 1 | 2016 | 68 | 0.480 |
Why?
|
| Myotomy | 3 | 2021 | 31 | 0.480 |
Why?
|
| Genitalia, Male | 1 | 2015 | 24 | 0.470 |
Why?
|
| Genitalia | 1 | 2015 | 20 | 0.470 |
Why?
|
| Genitalia, Female | 1 | 2015 | 26 | 0.470 |
Why?
|
| Humans | 61 | 2024 | 95802 | 0.470 |
Why?
|
| Esophageal Achalasia | 3 | 2020 | 61 | 0.450 |
Why?
|
| Clinical Competence | 11 | 2022 | 854 | 0.440 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2020 | 41 | 0.430 |
Why?
|
| Aged | 20 | 2024 | 20848 | 0.400 |
Why?
|
| Scrotum | 1 | 2013 | 18 | 0.400 |
Why?
|
| Male | 34 | 2024 | 45686 | 0.390 |
Why?
|
| Gastric Bypass | 3 | 2022 | 114 | 0.380 |
Why?
|
| Adult | 22 | 2024 | 28578 | 0.360 |
Why?
|
| Esophageal Motility Disorders | 2 | 2022 | 17 | 0.350 |
Why?
|
| Middle Aged | 25 | 2024 | 28208 | 0.350 |
Why?
|
| Deglutition Disorders | 2 | 2023 | 126 | 0.350 |
Why?
|
| Pain, Postoperative | 5 | 2021 | 277 | 0.330 |
Why?
|
| Female | 30 | 2024 | 49872 | 0.330 |
Why?
|
| Hernia, Umbilical | 2 | 2021 | 13 | 0.330 |
Why?
|
| Foreign Bodies | 2 | 2022 | 66 | 0.280 |
Why?
|
| Reoperation | 3 | 2021 | 707 | 0.260 |
Why?
|
| Stomach | 3 | 2016 | 115 | 0.260 |
Why?
|
| Catheterization, Peripheral | 1 | 2007 | 64 | 0.250 |
Why?
|
| Suture Techniques | 3 | 2016 | 143 | 0.250 |
Why?
|
| Esophageal Sphincter, Lower | 3 | 2021 | 32 | 0.240 |
Why?
|
| Operative Time | 2 | 2024 | 167 | 0.240 |
Why?
|
| Incisional Hernia | 3 | 2021 | 19 | 0.240 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 3904 | 0.230 |
Why?
|
| Body Mass Index | 3 | 2024 | 815 | 0.220 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2592 | 0.220 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2022 | 161 | 0.210 |
Why?
|
| Barrett Esophagus | 2 | 2015 | 94 | 0.210 |
Why?
|
| Laparotomy | 3 | 2019 | 63 | 0.200 |
Why?
|
| Physicians | 2 | 2021 | 706 | 0.200 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 11 | 0.180 |
Why?
|
| Weight Loss | 3 | 2022 | 240 | 0.170 |
Why?
|
| Virtual Reality | 1 | 2022 | 39 | 0.170 |
Why?
|
| Safety | 1 | 2021 | 147 | 0.170 |
Why?
|
| Gastroparesis | 1 | 2021 | 16 | 0.170 |
Why?
|
| Computer Simulation | 5 | 2022 | 1158 | 0.170 |
Why?
|
| Esophagoplasty | 1 | 2020 | 9 | 0.170 |
Why?
|
| Insufflation | 1 | 2020 | 10 | 0.170 |
Why?
|
| Biological Products | 1 | 2023 | 179 | 0.170 |
Why?
|
| Esophagitis, Peptic | 1 | 2020 | 10 | 0.160 |
Why?
|
| Electric Impedance | 4 | 2021 | 112 | 0.160 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 197 | 0.160 |
Why?
|
| Cholecystitis | 1 | 2020 | 17 | 0.160 |
Why?
|
| Cholelithiasis | 1 | 2020 | 36 | 0.160 |
Why?
|
| Cholecystectomy | 1 | 2020 | 26 | 0.160 |
Why?
|
| Diverticulitis | 1 | 2019 | 10 | 0.150 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2021 | 134 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2773 | 0.150 |
Why?
|
| Jejunum | 2 | 2016 | 80 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2020 | 295 | 0.150 |
Why?
|
| Teaching | 1 | 2020 | 154 | 0.150 |
Why?
|
| Patient Care Management | 1 | 2019 | 30 | 0.150 |
Why?
|
| Hernia, Ventral | 2 | 2017 | 28 | 0.150 |
Why?
|
| Perception | 1 | 2020 | 185 | 0.140 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 40 | 0.140 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 110 | 0.140 |
Why?
|
| Chronic Pain | 1 | 2020 | 186 | 0.130 |
Why?
|
| Acute Disease | 2 | 2019 | 859 | 0.130 |
Why?
|
| Common Bile Duct | 1 | 2017 | 19 | 0.130 |
Why?
|
| Self-Assessment | 1 | 2017 | 48 | 0.130 |
Why?
|
| Choledocholithiasis | 1 | 2017 | 14 | 0.130 |
Why?
|
| Prostatic Hyperplasia | 1 | 2018 | 97 | 0.130 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 43 | 0.130 |
Why?
|
| Self Concept | 1 | 2017 | 137 | 0.130 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 42 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2021 | 644 | 0.130 |
Why?
|
| Patient Safety | 1 | 2019 | 223 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2018 | 350 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 48 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2020 | 386 | 0.120 |
Why?
|
| Equipment Safety | 1 | 2016 | 32 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 475 | 0.120 |
Why?
|
| Pain Measurement | 3 | 2020 | 378 | 0.120 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 12 | 0.120 |
Why?
|
| Equipment Failure | 1 | 2016 | 128 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2022 | 4664 | 0.120 |
Why?
|
| Prostatectomy | 1 | 2019 | 480 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2016 | 199 | 0.120 |
Why?
|
| Esophagoscopy | 3 | 2020 | 91 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2019 | 2480 | 0.120 |
Why?
|
| Gastroenterology | 1 | 2017 | 157 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2019 | 3106 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 816 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 569 | 0.110 |
Why?
|
| Child | 2 | 2023 | 7618 | 0.110 |
Why?
|
| Time Factors | 3 | 2021 | 5561 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 682 | 0.110 |
Why?
|
| Contraindications | 1 | 2014 | 70 | 0.110 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 45 | 0.110 |
Why?
|
| Endoscopy | 3 | 2022 | 374 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 436 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 747 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2021 | 1010 | 0.090 |
Why?
|
| Esophagogastric Junction | 2 | 2021 | 35 | 0.080 |
Why?
|
| Swine | 2 | 2022 | 598 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 7215 | 0.080 |
Why?
|
| Elective Surgical Procedures | 2 | 2021 | 162 | 0.080 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 286 | 0.070 |
Why?
|
| Operating Rooms | 2 | 2022 | 138 | 0.070 |
Why?
|
| United States | 2 | 2021 | 7764 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2859 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2019 | 348 | 0.060 |
Why?
|
| Abdomen | 1 | 2007 | 124 | 0.060 |
Why?
|
| Equipment Design | 1 | 2007 | 427 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2007 | 145 | 0.060 |
Why?
|
| Weight Gain | 2 | 2016 | 129 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3639 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2020 | 417 | 0.050 |
Why?
|
| Patient Selection | 3 | 2019 | 708 | 0.050 |
Why?
|
| Manometry | 1 | 2022 | 45 | 0.050 |
Why?
|
| Vitamin D | 2 | 2015 | 273 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 3990 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2021 | 61 | 0.040 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 345 | 0.040 |
Why?
|
| Splenectomy | 1 | 2021 | 47 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2022 | 70 | 0.040 |
Why?
|
| Hernia | 1 | 2021 | 23 | 0.040 |
Why?
|
| Pylorus | 1 | 2021 | 15 | 0.040 |
Why?
|
| Gastric Emptying | 1 | 2021 | 26 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 192 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 72 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2022 | 196 | 0.040 |
Why?
|
| Spleen | 1 | 2021 | 420 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 246 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 71 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 1559 | 0.040 |
Why?
|
| Esophagus | 1 | 2020 | 111 | 0.040 |
Why?
|
| Publishing | 1 | 2021 | 94 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2022 | 263 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 169 | 0.040 |
Why?
|
| Device Removal | 1 | 2021 | 166 | 0.040 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 15 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 216 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2020 | 238 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 51 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 422 | 0.040 |
Why?
|
| Urinary Retention | 1 | 2018 | 46 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 162 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 87 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 360 | 0.030 |
Why?
|
| General Surgery | 1 | 2020 | 255 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2017 | 18 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 1192 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2021 | 502 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 361 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 883 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 900 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1008 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 55 | 0.030 |
Why?
|
| Surgical Stomas | 1 | 2016 | 22 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 131 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2611 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 369 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2020 | 391 | 0.030 |
Why?
|
| Granuloma | 1 | 1996 | 65 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2016 | 104 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 318 | 0.030 |
Why?
|
| Video Recording | 1 | 2016 | 215 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 34 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1996 | 263 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 98 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 943 | 0.030 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2014 | 8 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 323 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 386 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 252 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 287 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 5961 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 51 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 1996 | 217 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1765 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1981 | 0.020 |
Why?
|
| Illinois | 1 | 2014 | 530 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 28889 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 514 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 463 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2016 | 413 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1267 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1127 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1714 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1957 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 458 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 2386 | 0.010 |
Why?
|
| Prevalence | 1 | 1996 | 1349 | 0.010 |
Why?
|